Cannabis and Cancer, an Online Training for Oncology Nurses
Evaluation of a Digital Educational Intervention Regarding Safe and Efficient Cannabis Use with Young Adults Diagnosed with Cancer: a Pilot Study
1 other identifier
interventional
70
1 country
1
Brief Summary
The purpose of this study is to evaluate the preliminary effects and impacts of a digital educational intervention to support nurses' professional practice regarding safe cannabis use by young adults (18-39 years) diagnosed with cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 15, 2022
CompletedFirst Posted
Study publicly available on registry
December 23, 2022
CompletedStudy Start
First participant enrolled
January 4, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 18, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 18, 2024
CompletedFebruary 14, 2025
February 1, 2025
2 months
December 15, 2022
February 12, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in self-efficacy
The French version of the Continuing Professional Development Reaction (CPD-Reaction) questionnaire (Légaré et al., 2014) will be used. The CPD-Reaction is a 12-item theory-based self-report questionnaire designed to assess the impact of continuing professional development on different clinical practices and can be modified according to the behavior targeted by the continuing professional activity (ie, the Cannabis \& Cancer intervention). It is scored using a seven-point Likert scale ranging from strongly disagree (1) to strongly agree (7). The total score can range from 3 to 21 for self-efficacy. Higher scores indicate higher levels of self-efficacy. The CPD Reaction has adequate test-retest reliability (ie, weighted kappa coefficient between 0.43-0.53 for self-efficacy). The questionnaire has good internal consistency (Cronbach's alpha = 0.84).
4 weeks
Secondary Outcomes (8)
Change in attitudes
4 weeks
Change in intention
4 weeks
Change in knowledge
4 weeks
Number of training modules completed by participants (objective engagement)
4 weeks
Frequency of viewing modules/participants (objective engagement)
4 weeks
- +3 more secondary outcomes
Study Arms (2)
Cannabis & Cancer digital educational intervention
EXPERIMENTALThis intervention includes different asynchronous pedagogical modalities that allow, among other things, to reactivate the participants' previous knowledge and promote their autonomy in their learning process. These modalities focus on various problems that oncology nurses may encounter about the use of cannabis in oncology (eg, how to tackle the subject, what are the correct times to approach the topic). To this end, various pedagogical modalities that encourage the active participation of nurses are integrated into the training (eg, interactive videos, and quizzes). Scientific articles and links to external resources (official public websites) are also included so that nurses can consult the content at their own pace. Different aspects related to the use of cannabis are addressed in the training (eg, beneficial effects, and potential side effects).
Standard information regarding cannabis use in oncology
ACTIVE COMPARATORThe comparator is composed of an email with basic reliable non-personalized information on cannabis use in oncology (official public websites and scientific articles).
Interventions
The Cannabis \& Cancer intervention is available on Moodle learning management system in French language. It aims to influence nurses' self-efficacy, attitudes, intentions, and knowledge regarding the safe and efficient use of cannabis by young adults diagnosed with cancer.
Participants will be offered basic reliable non-personalized information on cannabis use in oncology (official public websites and scientific articles).
Eligibility Criteria
You may qualify if:
- Work in an oncology department (eg, radio-oncology, outpatient clinics)
- Work with people diagnosed with cancer, including young adults
- Understand, read, and write French
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Maisonneuve-Rosemont
Montreal, Quebec, H1T 2M4, Canada
Related Publications (1)
Vinette B, Cote J, Bilodeau K. Evaluation of a Digital Educational Intervention to Enhance Oncology Nurse Professional Practice to Support Safe Cannabis Use: A Pilot Study. J Contin Educ Health Prof. 2025 Dec 17. doi: 10.1097/CEH.0000000000000631. Online ahead of print.
PMID: 41427816DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Karine Bilodeau, PhD
Université de Montréal
- PRINCIPAL INVESTIGATOR
José Côté
Université de Montréal
- PRINCIPAL INVESTIGATOR
Billy Vinette, MSN
Univer
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 15, 2022
First Posted
December 23, 2022
Study Start
January 4, 2024
Primary Completion
March 18, 2024
Study Completion
May 18, 2024
Last Updated
February 14, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share